Update on Peripheral T-Cell Lymphoma


This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration.


  • Overview of PTCL
  • Current Treatment Options
  • New and Emerging Treatment Approaches
  • Clinical Trial Updates
  • Coping with Symptoms and Treatment Side Effects
  • Quality-of-Life Concerns
  • Questions & Answers


Neha Mehta-Shah, MD

Assistant Professor
Department of Medicine
Oncology Division
Medical Oncology
Washington University School of Medicine at St. Louis

Dr. Neha Mehta-Shah is an Assistant Professor in the Division of Oncology at Washington University School of Medicine and specializes in Lymphoma. She received her MD from Northwestern University’s Feinberg School of Medicine, and Masters of Science in Clinical Investigation from Washington University School of Medicine. Dr. Mehta-Shah completed residency training in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center, where she was selected as Chief Resident. She then completed fellowship in Hematology/Oncology at Memorial Sloan Kettering Cancer Center. She is board certified in Medical Oncology, Hematology and Internal Medicine.

Dr. Mehta-Shah’s primary focus is the development of novel therapies for rare lymphomas including T-cell lymphomas and biomarkers to help predict response or resistance to therapy. She is the PI on several investigator initiated clinical trials in lymphoma, and extramural and intramural grants. She serves on the National Comprehensive Cancer Network guidelines for T-cell lymphoma. She also has an interest in medical education and is a core faculty member of the Hematology/Oncology Fellowship program.

Continuing Education

Production Date: